MoonLake Immunotherapeutics (MLTX) EPS (Basic) (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly EPS (Basic) came in at -$0.98 in Q1 2026, down 52.48% year-on-year from -$2.06 in Q1 2025, and little changed quarter-over-quarter from -$0.98 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) EPS (Basic) (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.98 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 52.48% year-over-year to -$0.98 in Q1 2026; TTM through Mar 2026 was -$3.64, a 55.72% decrease from a year earlier, with the FY2025 full-year figure at -$3.57, down 85.27% from the prior year.
- EPS (Basic) held at -$0.98 in Q1 2026 per MLTX's latest filing, from -$0.98 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.16 in Q4 2023 and bottomed at -$3.17 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.56 (2022), against an average of -$0.71.
- Across the five-year window, EPS (Basic) sank 25773.85% in 2022 and soared 90.12% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.56 in 2022, then surged by 71.37% to -$0.16 in 2023, then plunged by 359.6% to -$0.74 in 2024, then slumped by 32.47% to -$0.98 in 2025, then dropped by 0.05% to -$0.98 in 2026.
- Per Business Quant, the three latest MLTX EPS (Basic) figures stand at -$0.98 (Q1 2026), -$0.98 (Q4 2025), and -$1.12 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | MoonLake Immunotherapeutics | 1.35 Bn | 991.29 Mn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -1.12 |
| Jun 30, 2025 | -0.89 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.74 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | -0.56 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -3.17 |
| Dec 31, 2021 | -4.50 |
| Sep 30, 2021 | -2.63 |
| Jun 30, 2021 | -2.90 |